Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenNIH

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Nov 5, 2027
Closes
View opportunity →
OpenNIH

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

$1,500,000
Award ceiling
Nov 5, 2027
Closes
View opportunity →
OpenNIH

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Nov 5, 2027
Closes
View opportunity →
OpenNIH

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Nov 8, 2027
Closes
View opportunity →
OpenNIH

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

Nov 12, 2027
Closes
View opportunity →
OpenNIH

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

Nov 12, 2027
Closes
View opportunity →
OpenNIH

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

$350,000
Total funding
Nov 12, 2027
Closes
View opportunity →
OpenNIH

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

Nov 12, 2027
Closes
View opportunity →
OpenNIH

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

$6,250,000
Award ceiling
Nov 15, 2027
Closes
View opportunity →
OpenNIH

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Nov 15, 2027
Closes
View opportunity →
OpenNIH

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Nov 16, 2027
Closes
View opportunity →
OpenNIH

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Nov 16, 2027
Closes
View opportunity →